Naturex-DBS launches organic cranberry powder to US market

- Last updated on GMT

Naturex-DBS launches organic cranberry powder to US market

Related tags: Urinary tract, Urinary tract infection, Cranberry

Botanical extract giant Naturex-DBS has launched a USDA NOP certified organic cranberry powder to the US market, stating it is a logical extension of its cranberry powders range targeting urinary tract health.

Pacran Organic broadens the market potential for the cranberry nutraceutical ingredient, which is supported by six U.S. and three international patents.

“DBS continues to be the leader in cranberry science and innovation,”​ said Dan Souza, Sr. Director of Sales and Marketing, “Pacran Organic is the only clinically supported, health claim substantiated cranberry powder available in an organic format. Like conventional Pacran, Pacran Organic uses a proprietary blend of the whole fruit to deliver the full spectrum benefits of the whole cranberry.

“Pacran Organic is a logical extension of the 100% all natural Pacran line of cranberry powders targeted towards urinary tract health.”

The link between cranberries and urinary tract health is well established, and linked to its proanthocyanidin (PAC) content. In 2004 France became the first country to approve a health claim for the North American cranberry (Vaccinium macrocarpon​) with at least 36mg of proanthocyanidins (PAC) to “help reduce the adhesion of certain E. coli bacteria to the urinary tract walls”​, and subsequently fight urinary tract infections (UTIs).

Related topics: Suppliers, Polyphenols, Women's health

Related news

Show more

Related products

show more

Gemini Pharmaceuticals and Transparency

Gemini Pharmaceuticals and Transparency

Gemini Pharmaceuticals | 01-Sep-2019 | Application Note

The industry has shown improvement in its transparency in the past 5 years. Per the regulations, a Brand Owner is 100% responsible for the quality of...

Clinically Proven Omega-3 formula for Joint Health

Clinically Proven Omega-3 formula for Joint Health

KD Pharma Group | 01-Sep-2019 | Data Sheet

KD Nutra is pleased to announce the completion of a clinical trial for its Move3™ omega-3 joint formulation. The trial has shown that Move3™ has a significant...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars